Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Infectious Endocarditis in the Elderly – Comparative Study of Clinical Features, Course and Outcomes

https://doi.org/10.20996/1819-6446-2020-03-02

Full Text:

Abstract

In the context of the increased incidence of infectious endocarditis (IE) in the elderly, an assessment of clinical features of IE in elderly patients is still controversial.

Aim. To study the clinical features and outcomes of IE in patients aged ≥65 years.

Material and methods. А comparative assessment of risk factors, etiology, clinical manifestations, outcomes was performed in 75 IE patients ≥65 years old and in 356 IE patients <65 years old.

Results. In patients ≥65 years old IE was more often associated with previous medical care (odds ratio [OR]=14.9; 95% confidence interval [95%CI] 8.6;25.9), infections and tumors of the genitourinary system or tumors of the gastrointestinal tract (OR=12.6; 95%CI 6.4;24.6); there were more concomitant oncological diseases (OR=66.2; 95%CI 19.3;226.8), diabetes mellitus (OR=9.9; 95%CI 4.5;22.1), chronic kidney disease (OR=27.0; 95%CI 13.6;53.3). In patients ≥65 years old compared with non-drug users IE patients <65 years old (n=266), the incidence of enterococcal IE was higher (OR=3.3; 95%CI 1.4;7.9); the timing of IE diagnosis was longer – 60 (37;152) vs 30 (20;110) days (p<0.05); cardiac surgery was performed less often (8% vs 24.8%; p<0.05); in-hospital mortality was almost two-fold higher. However, with the exclusion from the mortality rate assessment of postmortem diagnosed IE cases in-hospital mortality in patients ≥65 years old and patients <65 years old did not differ significantly (14.8% vs 12.2% in non-drug users <65 years old and 14.9% in drug-users IE).

Conclusion. Late diagnosis of IE and comorbidity, which limits the possibility of cardiac surgery, are the most important prognostic unfavorable features of IE in the elderly.

About the Authors

N. S. Chipigina
Pirogov Russian National Research Medical University
Russian Federation

Natalia S. Chipigina – MD, PhD, Associate Professor, Chair of Faculty Therapy named after Academician A.I. Nesterov

 Ostrovityanova ul. 1, Moscow, 117997



N. Yu. Karpova
Pirogov Russian National Research Medical University
Russian Federation

Nina Yu. Karpova – MD, PhD, Professor, Chair of Faculty Therapy named after Academician A.I. Nesterov

Ostrovityanova ul. 1, Moscow, 117997



D. A. Anichkov
Pirogov Russian National Research Medical University
Russian Federation

Dmitrii A. Anichkov – MD, PhD, Associate Professor, Chair of Faculty Therapy named after Academician A.I. Nesterov

Ostrovityanova ul. 1, Moscow, 117997



T. B. Kondratieva
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

Tatiana B. Kondratieva – MD, PhD, Associate Professor, Chair of Hospital Therapy №1

Trubetskaya ul. 8-2, Moscow, 119991



References

1. Vatutin N.T., Taradin G.G., Tchaus E.A., Smirnova A.S. Infective endocarditis in elderly: from etiology to treatment and prevention. Russian Journal of Cardiology. 2016;(1):80-9 (In Russ.). DOI:10.15829/1560-4071-2016-1-80-89.

2. Slipczuk L., Codolosa J.N., Davila C.D., et al. Infective endocarditis epidemiology over five decades: a systematic review. PLoS One. 2013;8(12):e82665. DOI:10.1371/journal.pone.0082665.

3. Sy R.W., Kritharides L. Health care exposure and age in infective endocarditis: results of a contemporary population-based profile of 1536 patients in Australia. Eur Heart J, 2010;31(15):1890-7. DOI:10.1093/eurheartj/ehq110.

4. Nakatani S., Mitsutake K., Ohara T., et al.; CADRE Investigators. Recent picture of infective endocarditis in Japan--lessons from Cardiac Disease Registration (CADRE-IE). Circ J. 2013;77(6):1558-64. DOI:10.1253/circj.CJ-12-1101.

5. Selton-Suty Ch., Célard M, Le Moing V., et al.; AEPEI Study Group. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis. 2012;54(9):1230- 9. DOI:10.1093/cid/cis199.

6. DeSimone D.C., Tleyjeh I.M., Correa de Sa D.D., et al. Temporal trends in infective endocarditis epidemiology from 2007 to 2013 in Olmsted County, MN. Am Heart J. 2015t;170(4):830-6. DOI:10.1016/j.ahj.2015.07.007.

7. Ursi M.P., Durante Mangoni E., Rajani R., et al. Infective Endocarditis in the Elderly: Diagnostic and Treatment Options. Drugs Aging. 2019;36(2):115-24. DOI:10.1007/s40266-018-0614-7.

8. Di Salvo G., Thuny F., Rosenberg V., et al. Endocarditis in the elderly: clinical, echocardiographic, and prognostic features. Eur Heart J. 2003;24(17):1576-83. DOI:10.1016/S0195-668X(03)00309-9.

9. Durante-Mangoni E., Bradley S, Selton-Suty C., et al.; International Collaboration on Endocarditis Prospective Cohort Study Group.Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study. Arch Intern Med. 2008;168(19):2095-103. DOI:10.1001/archinte.168.19.2095.

10. Habib G., Hoen B., Tornos P., et al.; ESC Committee for Practice Guidelines. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009) The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC) Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009;30(19):2369- 413. DOI:10.1093/eurheartj/ehp285.

11. Habib G., Lancellotti P., Antunes M.J., et al.; ESC Scientific Document Group. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075-128. DOI:10.1093/eurheartj/ehv319.

12. Buchholtz K., Larsen C.T., Hassager C., Bruun N.E. In infectious endocarditis patients mortality is highly related to kidney function at time of diagnosis: a prospective observational cohort study of 231 cases. Eur J Intern Med. 2009;20(4):407-10. DOI:10.1016/j.ejim.2008.12.017.

13. Kourany W.M., Miro J.M., Moreno A., et al. Influence of diabetes mellitus on the clinical manifestations and prognosis of infective endocarditis: a report from the International Collaboration on Endocarditis-Merged Database. Scand J Infect Dis. 2006;38(8):613-9. DOI:10.1080/00365540600617017.

14. Chipigina N.S., Karpova N.Y., Barsegyan V.A., Timofeev V.T. Infective endocarditis and malignant neoplasms: facts and hypotheses. The Clinician. 2018;12(1):17-24 (In Russ.) DOI:10.17650/1818-8338-2018-12-1-17-24.

15. Cecchi E., Chirillo F., Castiglione A., et al. Clinical epidemiology in Italian Registry of Infective Endocarditis (RIEI): Focus on age, intravascular devices and enterococci. Int J Cardiol. 2015;190:151-6. DOI:10.1016/j.ijcard.2015.04.123.

16. Cahill T.J., Baddour L.M., Habib G., et al. Challenges in Infective Endocarditis. J Am Coll Cardiol. 2017;69(3):325-344. DOI:10.1016/j.jacc.2016.10.066.

17. Aguilar-Company J., Pigrau C., Fernández-Hidalgo N., et al. Native vertebral osteomyelitis in aged patients: distinctive features. An observational cohort study. Infection. 2018;46(5):679-86. DOI:10.1007/s15010-018-1177-6.


For citation:


Chipigina N.S., Karpova N.Yu., Anichkov D.A., Kondratieva T.B. Infectious Endocarditis in the Elderly – Comparative Study of Clinical Features, Course and Outcomes. Rational Pharmacotherapy in Cardiology. 2020;16(2):166-174. (In Russ.) https://doi.org/10.20996/1819-6446-2020-03-02

Views: 233


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)